跳转至内容
Merck
CN

EMU078421

MISSION® esiRNA

targeting mouse Uba2

登录 查看组织和合同定价。

选择尺寸


关于此项目

NACRES:
NA.51
UNSPSC Code:
41105324
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

MISSION® esiRNA, targeting mouse Uba2

description

Powered by Eupheria Biotech

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

GCTCAGGTTGCCAAAGAAAGTGTGCTCCAGTTCCACCCCCAAGCCAACATTGAGGCTCACCATGACAGCATCATGAACCCAGACTATAATGTGGAGTTTTTTCGACAGTTTATATTGGTCATGAATGCATTAGATAACAGAGCTGCACGAAACCACGTGAATAGGATGTGTCTGGCCGCTGATGTGCCTCTCATTGAGAGCGGGACTGCTGGGTATCTCGGACAGGTGACCACTATCAAGAAGGGTGTGACTGAGTGTTACGAATGTCACCCTAAGCCTACCCAGAGGACGTTCCCTGGCTGTACGATTCGGAACACGCCTTCAGAACCTATCCATTGCATCGTATGGGCCAAGTATTTGTTCAACCAGCTGTTTGGAGAGGAAGATGCTGATCAAGAAGTGTCTCCTGACAGAGCTGACCCTGAGGCTGCTTGGGAACCAACAGAGGCTGAAGC

Ensembl | mouse accession no.

NCBI accession no.

shipped in

ambient

storage temp.

−20°C

Quality Level

Gene Information

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

存储类别

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Xingyue He et al.
PloS one, 10(4), e0123882-e0123882 (2015-04-11)
SUMOylation is a post-translational ubiquitin-like protein modification pathway that regulates important cellular processes including chromosome structure, kinetochore function, chromosome segregation, nuclear and sub-nuclear organization, transcription and DNA damage repair. There is increasing evidence that the SUMO pathway is dysregulated in
Xiaoke Liu et al.
Journal of hematology & oncology, 8, 67-67 (2015-06-13)
SUMO-activating enzyme subunit 2 (SAE2) is the sole E1-activating enzyme required for numerous important protein SUMOylation, abnormal of which is associated with carcinogenesis. SAE2 inactivation was recently reported to be a therapeutic strategy in cancers with Myc overexpression. However, the

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持